MASSARI, FRANCESCO
MASSARI, FRANCESCO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group
2026 Calabrò, Concetta; Ciccimarra, Francesco; Rizzo, Alessandro; Cazzato, Gerardo; Della Mura, Mario; Taha, Tarek; Bourlon, Maria T; Melichar, Bohuslav; Studentova, Hana; Schieber, Timothy J; Nardulli, Patrizia; Molina-Cerrillo, Javier; Monteiro, Fernando Sabino Marques; Soares, Andrey; Massafra, Raffaella; Mollica, Veronica; Massari, Francesco; Kucharz, Jakub; Santoni, Matteo
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study
2026 Büttner, Thomas; Rizzo, Mimma; Bernal Vaca, Laura; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Juárez, Alvaro; Buchler, Tomas; Seront, Emmanuel; Kucharz, Jakub; Gandur Quiroga, María Natalia; Bourlon, Maria T; Bögemann, Martin; Kopecky, Jindrich; Rescigno, Pasquale; Fiala, Ondrej; Rodriguez-Vida, Alejo; Myint, Zin W; Ürün, Yüksel; Scagliarini, Sarah; Poprach, Alexandr; Matthews, Diana; Li, Haoran; Rizzo, Alessandro; Mosca, Alessandra; Lenci, Edoardo; Melichar, Bohuslav; Wenzel, Mike; Mandell, Philipp; Massari, Francesco; Antonarakis, Emmanuel S; Santoni, Matteo
Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis
2026 Vitale, Elsa; Maistrello, Lorenza; Ciccimarra, Francesco; Rizzo, Alessandro; Soares, Andrey; Brunetti, Oronzo; Mollica, Veronica; Maiorano, Brigida Anna; Maiorano, Mauro Francesco Pio; Monteiro, Fernando Sabino Marques; Massari, Francesco; Santoni, Matteo
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?
2026 Cerbone, Linda; Roviello, Giandomenico; Calabrò, Fabio; Taha, Tarek; Grande, Enrique; Binz, Kirstin; Kanesvaran, Ravindran; Pirstuk, Alina; Fiala, Ondřej; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Rizzo, Alessandro; Pichler, Renate; Myint, Zin W; Poprach, Alexandr; Facchini, Gaetano; Bohuslav, Melichar; Studentova, Hana; Morelli, Franco; Buchler, Tomas; Mennitto, Alessia; Tural, Deniz; Formisano, Luigi; Orejana, Inmaculada; Catalano, Martina; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Gupta, Shilpa; Massari, Francesco; Santoni, Matteo
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features
2026 Ricci, Costantino; Di Sciascio, Luisa; Ambrosi, Francesca; Orsatti, Agnese; Grillini, Alessia; Franchini, Eugenia; Mollica, Veronica; Massari, Francesco; Bianchi, Federico Mineo; Vasuri, Francesco; Lobo, João; Tavares, Nuno Tiago; Fernandes-Pontes, Fernanda; Acosta, Andres Martin; Fiorentino, Michelangelo
PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an "EMBARK-Like" cohort
2026 Droghetti, Matteo; Pirelli, Valerio; Ceci, Francesco; Farolfi, Andrea; Bauckneht, Matteo; Lanfranchi, Francesco; Di Giorgio, Andrea; Castellucci, Paolo; Sgro, Caterina Maria Paola; Artigas, Carlos; Leite, Jose; Corona, Paola; Shagera, Qaid Ahmed; Moreira, Renata; González, Christian; Queiroz, Marcelo; De Galiza Barbosa, Felipe; Rovera, Guido; Deandreis, Desiree; Tamburini, Sara; Nanni, Lorenzo; Bevilacqua, Federico; Piazza, Pietro; Mottaran, Angelo; Mollica, Veronica; Massari, Francesco; Fanti, Stefano; Bianchi, Lorenzo; Schiavina, Riccardo
Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV)
2026 Mollica, Veronica; Massari, Francesco; Fujita, Kazutoshi; Giannatempo, Patrizia; Grande, Enrique; Büttner, Thomas; Bourlon, Maria T; Taha, Tarek; Fukuokaya, Wataru; Myint, Zin W; Pichler, Renate; Binz, Kirstin; Molina-Cerrillo, Javier; Kopecky, Jindrich; De Liaño, Alfonso Gómez; Kucharz, Jakub; Fiala, Ondřej; Matrana, Marc R; Kopp, Ray Manneh; Di Civita, Mattia Alberto; Zgura, Anca; Ansari, Jawaher; Kihnel, Randi; De Felice, Francesca; Angel, Martín; Monteiro, Fernando Sabino M; Soares, Andrey; Urun, Yuksel; Buti, Sebastiano; Santini, Daniele; Santoni, Matteo
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors
2026 Mandel, Philipp; Wenzel, Mike; Chun, Felix; Graefen, Markus; Gandur Quiroga, María Natalia; Rodriguez-Vida, Alejo; Bourlon, Maria T; Myint, Zin W; Bernal, Laura; Ürün, Yüksel; Kopp, Ray Manneh; Juan Fita, Maria José; Zapata Laguado, Martin Ignacio; Büttner, Thomas; Fiala, Ondrej; Fujita, Kazutoshi; Li, Haoran; Kopecky, Jindrich; Matrana, Marc R; Bögemann, Martin; Carrozza, Francesco; Zgura, Anca; Buchler, Tomas; Matthews, Diana; Yazgan, Sati Coskun; Lenci, Edoardo; Ansari, Jawaher; Marques Monteiro, Fernando Sabino; Soares, Andrey; Rizzo, Alessandro; Ciccimarra, Francesco; Massari, Francesco; Jazieh, Abdul Rahman; Santoni, Matteo
177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study
2025 Mandel, Philipp; Groener, Daniel; Follacchio, Giulia; Ürün, Yüksel; Bourlon, Maria T; Sabet, Amir; Grünwald, Frank; Tural, Deniz; Büttner, Thomas; Kopp, Ray Manneh; Taha, Tarek; Chun, Felix Kh; Facchini, Gaetano; Myint, Zin W; Seront, Emmanuel; Conteduca, Vincenza; Quiroga, María Natalia Gandur; Aurilio, Gaetano; Palacios, Georgia Anguera; Bögemann, Martin; Roviello, Giandomenico; Matrana, Marc R; Sammarco, Enrico; Laguado, Martin Ignacio Zapata; Galli, Luca; Ansari, Jawaher; Danielli, Linda; Molina-Cerrillo, Javier; Rescigno, Pasquale; Yazgan, Sati Coskun; Bastos, Diogo Assed; Jazieh, Abdul Rahman; Monteiro, Fernando Sabino Marques; Soares, Andrey; Massari, Francesco; Wenzel, Mike; Capoccetti, Francesca; Santoni, Matteo
Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?
2025 Danielli, Linda; Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Santoni, Matteo; Massari, Francesco
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project
2025 Rizzo, Alessandro; Myint, Zin W; Ciccimarra, Francesco; Zgura, Anca; Matrana, Marc R; Büttner, Thomas; Kopecky, Jindrich; Vida, Alejo Rodriguez; Rizzo, Mimma; Fujita, Kazutoshi; Brunetti, Oronzo; Santini, Daniele; Park, Se Hoon; Formisano, Luigi; Poprach, Alexandr; Kucharz, Jakub; Comes, Maria Colomba; Bove, Samantha; Fanizzi, Annarita; Massafra, Raffaella; Cazzato, Gerardo; Monteiro, Fernando Sabino Marques; Mollica, Veronica; Massari, Francesco; Cerrillo, Javier Molina; Santoni, Matteo
Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study
2025 Fiala, Ondřej; Buti, Sebastiano; Fujita, Kazutoshi; de Liaño, Alfonso Gómez; Fukuokaya, Wataru; Kimura, Takahiro; Yanagisawa, Takafumi; Giannatempo, Patrizia; Angel, Martin; Mennitto, Alessia; Molina-Cerrillo, Javier; Bourlon, Maria T; Soares, Andrey; Takeshita, Hideki; Calabrò, Fabio; Ortega, Cinzia; Kucharz, Jakub; Milella, Michele; Seront, Emmanuel; Park, Se Hoon; Tural, Deniz; Benedetti, Giovanni; Ürün, Yüksel; Battelli, Nicola; Melichar, Bohuslav; Poprach, Alexandr; Buchler, Tomas; Kopecký, Jindřich; Conteduca, Vincenza; Monteiro, Fernando Sabino Marques; Massari, Francesco; Gupta, Shilpa; Santoni, Matteo
Correction to: The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor
2025 Ricci, Costantino; Di Sciascio, Luisa; Ambrosi, Francesca; Grillini, Marco; Mollica, Veronica; Massari, Francesco; Fiorentino, Michelangelo; De Leo, Antonio; Idrees, Muhammad T.; Ulbright, Thomas M.; Acosta, Andres Martin
Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges
2025 Danielli, Linda; Tassinari, Elisa; Marchetti, Andrea; Rosellini, Matteo; Mollica, Veronica; Cheng, Liang; Massari, Francesco
Decreased Appetite in Cancer Patients Treated with immune checkpoint inhibitors (ICIs): The MOUSEION-012 Systematic Review and Meta-Analysis
2025 Vitale, Elsa; Rizzo, Alessandro; Maistrello, Lorenza; Cauli, Omar; Mollica, Veronica; Marques Monteiro, Fernando Sabino; Soares, Andrey; Massari, Francesco; Santoni, Matteo
Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?
2025 Marchetti, Andrea; Mollica, Veronica; Brocchi, Stefano; Cattabrigra, Arrigo; Tassinari, Elisa; Rosellini, Matteo; Massari, Francesco
Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma
2025 Santoni, Matteo; Mollica, Veronica; Rizzo, Alessandro; Massari, Francesco
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort
2025 Fiala, Ondrej; Grillone, Francesco; Fujita, Kazutoshi; Grande, Enrique; Giannatempo, Patrizia; Taha, Tarek; Myint, Zin W.; Büttner, Thomas; De Liaño, Alfonso Gómez; Kanesvaran, Ravindran; Facchini, Gaetano; Yano, Akihiro; Formisano, Luigi; Poprach, Alexandr; Conteduca, Vincenza; Pirshtuk, Alina; Studentova, Hana; Kopecky, Jindrich; Sammarco, Enrico; Mota, Augusto; Incorvaia, Lorena; Nasso, Cecilia; Maffezzoli, Michele; Ghose, Aruni; Soares, Andrey; Buti, Sebastiano; Marques Monteiro, Fernando Sabino; Massari, Francesco; Gupta, Shilpa; Bellmunt, Joaquim; Banna, Giuseppe Luigi; Santoni, Matteo
Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experience
2025 Mottaran, Angelo; Piazza, Pietro; Dababneh, Hussam; Scarlatti, Riccardo; Catanzaro, Calogero; Pieri, Jacopo; Biolcati, Stefano; Droghetti, Matteo; Massari, Francesco; Chessa, Francesco; Bianchi, Lorenzo; Schiavina, Riccardo; Brunocilla, Eugenio
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
2025 Roviello, Giandomenico; Molina-Cerrillo, Javier; Massari, Francesco; Cerbone, Linda; Fiala, Ondrej; Fornarini, Giuseppe; Monteiro, Fernando Sabino Marques; Cattrini, Carlo; Landmesser, Johannes; Messina, Carlo; Zgura, Anca; Rebuzzi, Sara Elena; Soares, Andrey; Carrozza, Francesco; Ansari, Jawaher; Grillone, Francesco; Küronya, Zsófia; Incorvaia, Lorena; Bhuva, Dipen; Ortega, Cinzia; Nasso, Cecilia; Kanesvaran, Ravindran; Zampiva, Ilaria; Porta, Camillo; Buti, Sebastiano; Santoni, Matteo
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group | Calabrò, Concetta; Ciccimarra, Francesco; Rizzo, Alessandro; Cazzato, Gerardo; Della Mura, Mario;... Taha, Tarek; Bourlon, Maria T; Melichar, Bohuslav; Studentova, Hana; Schieber, Timothy J; Nardulli, Patrizia; Molina-Cerrillo, Javier; Monteiro, Fernando Sabino Marques; Soares, Andrey; Massafra, Raffaella; Mollica, Veronica; Massari, Francesco; Kucharz, Jakub; Santoni, Matteo | 2026-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study | Büttner, Thomas; Rizzo, Mimma; Bernal Vaca, Laura; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa...; Juárez, Alvaro; Buchler, Tomas; Seront, Emmanuel; Kucharz, Jakub; Gandur Quiroga, María Natalia; Bourlon, Maria T; Bögemann, Martin; Kopecky, Jindrich; Rescigno, Pasquale; Fiala, Ondrej; Rodriguez-Vida, Alejo; Myint, Zin W; Ürün, Yüksel; Scagliarini, Sarah; Poprach, Alexandr; Matthews, Diana; Li, Haoran; Rizzo, Alessandro; Mosca, Alessandra; Lenci, Edoardo; Melichar, Bohuslav; Wenzel, Mike; Mandell, Philipp; Massari, Francesco; Antonarakis, Emmanuel S; Santoni, Matteo | 2026-01-01 | PROSTATE CANCER AND PROSTATIC DISEASES | - | 1.01 Articolo in rivista | Prostate Cancer and Prostatic Diseases 2026 [Enza mHSPC ARON-3].pdf |
| Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis | Vitale, Elsa; Maistrello, Lorenza; Ciccimarra, Francesco; Rizzo, Alessandro; Soares, Andrey; Brun...etti, Oronzo; Mollica, Veronica; Maiorano, Brigida Anna; Maiorano, Mauro Francesco Pio; Monteiro, Fernando Sabino Marques; Massari, Francesco; Santoni, Matteo | 2026-01-01 | CANCER AND METASTASIS REVIEWS | - | 1.01 Articolo in rivista | - |
| Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario? | Cerbone, Linda; Roviello, Giandomenico; Calabrò, Fabio; Taha, Tarek; Grande, Enrique; Binz, Kirst...in; Kanesvaran, Ravindran; Pirstuk, Alina; Fiala, Ondřej; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Rizzo, Alessandro; Pichler, Renate; Myint, Zin W; Poprach, Alexandr; Facchini, Gaetano; Bohuslav, Melichar; Studentova, Hana; Morelli, Franco; Buchler, Tomas; Mennitto, Alessia; Tural, Deniz; Formisano, Luigi; Orejana, Inmaculada; Catalano, Martina; Buti, Sebastiano; Monteiro, Fernando Sabino Marques; Soares, Andrey; Gupta, Shilpa; Massari, Francesco; Santoni, Matteo | 2026-01-01 | FRONTIERS IN IMMUNOLOGY | - | 1.01 Articolo in rivista | fimmu-17-1667155.pdf; table 1.docx |
| New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features | Ricci, Costantino; Di Sciascio, Luisa; Ambrosi, Francesca; Orsatti, Agnese; Grillini, Alessia; Fr...anchini, Eugenia; Mollica, Veronica; Massari, Francesco; Bianchi, Federico Mineo; Vasuri, Francesco; Lobo, João; Tavares, Nuno Tiago; Fernandes-Pontes, Fernanda; Acosta, Andres Martin; Fiorentino, Michelangelo | 2026-01-01 | VIRCHOWS ARCHIV | - | 1.01 Articolo in rivista | - |
| PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an "EMBARK-Like" cohort | Droghetti, Matteo; Pirelli, Valerio; Ceci, Francesco; Farolfi, Andrea; Bauckneht, Matteo; Lanfran...chi, Francesco; Di Giorgio, Andrea; Castellucci, Paolo; Sgro, Caterina Maria Paola; Artigas, Carlos; Leite, Jose; Corona, Paola; Shagera, Qaid Ahmed; Moreira, Renata; González, Christian; Queiroz, Marcelo; De Galiza Barbosa, Felipe; Rovera, Guido; Deandreis, Desiree; Tamburini, Sara; Nanni, Lorenzo; Bevilacqua, Federico; Piazza, Pietro; Mottaran, Angelo; Mollica, Veronica; Massari, Francesco; Fanti, Stefano; Bianchi, Lorenzo; Schiavina, Riccardo | 2026-01-01 | PROSTATE CANCER AND PROSTATIC DISEASES | - | 1.01 Articolo in rivista | - |
| Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV) | Mollica, Veronica; Massari, Francesco; Fujita, Kazutoshi; Giannatempo, Patrizia; Grande, Enrique;... Büttner, Thomas; Bourlon, Maria T; Taha, Tarek; Fukuokaya, Wataru; Myint, Zin W; Pichler, Renate; Binz, Kirstin; Molina-Cerrillo, Javier; Kopecky, Jindrich; De Liaño, Alfonso Gómez; Kucharz, Jakub; Fiala, Ondřej; Matrana, Marc R; Kopp, Ray Manneh; Di Civita, Mattia Alberto; Zgura, Anca; Ansari, Jawaher; Kihnel, Randi; De Felice, Francesca; Angel, Martín; Monteiro, Fernando Sabino M; Soares, Andrey; Urun, Yuksel; Buti, Sebastiano; Santini, Daniele; Santoni, Matteo | 2026-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | Cancer Immunol Immunoth 2026 [Squamous UC ARON-2].pdf; 262_2026_4328_MOESM1_ESM.docx |
| Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors | Mandel, Philipp; Wenzel, Mike; Chun, Felix; Graefen, Markus; Gandur Quiroga, María Natalia; Rodri...guez-Vida, Alejo; Bourlon, Maria T; Myint, Zin W; Bernal, Laura; Ürün, Yüksel; Kopp, Ray Manneh; Juan Fita, Maria José; Zapata Laguado, Martin Ignacio; Büttner, Thomas; Fiala, Ondrej; Fujita, Kazutoshi; Li, Haoran; Kopecky, Jindrich; Matrana, Marc R; Bögemann, Martin; Carrozza, Francesco; Zgura, Anca; Buchler, Tomas; Matthews, Diana; Yazgan, Sati Coskun; Lenci, Edoardo; Ansari, Jawaher; Marques Monteiro, Fernando Sabino; Soares, Andrey; Rizzo, Alessandro; Ciccimarra, Francesco; Massari, Francesco; Jazieh, Abdul Rahman; Santoni, Matteo | 2026-01-01 | EUROPEAN UROLOGY OPEN SCIENCE | - | 1.01 Articolo in rivista | EU Open Science 2026 [ARON-3 mHSPC Local Treatment].pdf |
| 177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study | Mandel, Philipp; Groener, Daniel; Follacchio, Giulia; Ürün, Yüksel; Bourlon, Maria T; Sabet, Amir...; Grünwald, Frank; Tural, Deniz; Büttner, Thomas; Kopp, Ray Manneh; Taha, Tarek; Chun, Felix Kh; Facchini, Gaetano; Myint, Zin W; Seront, Emmanuel; Conteduca, Vincenza; Quiroga, María Natalia Gandur; Aurilio, Gaetano; Palacios, Georgia Anguera; Bögemann, Martin; Roviello, Giandomenico; Matrana, Marc R; Sammarco, Enrico; Laguado, Martin Ignacio Zapata; Galli, Luca; Ansari, Jawaher; Danielli, Linda; Molina-Cerrillo, Javier; Rescigno, Pasquale; Yazgan, Sati Coskun; Bastos, Diogo Assed; Jazieh, Abdul Rahman; Monteiro, Fernando Sabino Marques; Soares, Andrey; Massari, Francesco; Wenzel, Mike; Capoccetti, Francesca; Santoni, Matteo | 2025-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | EJC 2025 [ARON-3 LuPSMA vs Caba].pdf; 1-s2.0-S0959804925005751-mmc1.docx |
| Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years? | Danielli, Linda; Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Santo...ni, Matteo; Massari, Francesco | 2025-01-01 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | - | 1.01 Articolo in rivista | - |
| Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project | Rizzo, Alessandro; Myint, Zin W; Ciccimarra, Francesco; Zgura, Anca; Matrana, Marc R; Büttner, Th...omas; Kopecky, Jindrich; Vida, Alejo Rodriguez; Rizzo, Mimma; Fujita, Kazutoshi; Brunetti, Oronzo; Santini, Daniele; Park, Se Hoon; Formisano, Luigi; Poprach, Alexandr; Kucharz, Jakub; Comes, Maria Colomba; Bove, Samantha; Fanizzi, Annarita; Massafra, Raffaella; Cazzato, Gerardo; Monteiro, Fernando Sabino Marques; Mollica, Veronica; Massari, Francesco; Cerrillo, Javier Molina; Santoni, Matteo | 2025-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | Clinical and Experimental Medicine 2026 [ARON-2 Bone mets EV].pdf |
| Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study | Fiala, Ondřej; Buti, Sebastiano; Fujita, Kazutoshi; de Liaño, Alfonso Gómez; Fukuokaya, Wataru; K...imura, Takahiro; Yanagisawa, Takafumi; Giannatempo, Patrizia; Angel, Martin; Mennitto, Alessia; Molina-Cerrillo, Javier; Bourlon, Maria T; Soares, Andrey; Takeshita, Hideki; Calabrò, Fabio; Ortega, Cinzia; Kucharz, Jakub; Milella, Michele; Seront, Emmanuel; Park, Se Hoon; Tural, Deniz; Benedetti, Giovanni; Ürün, Yüksel; Battelli, Nicola; Melichar, Bohuslav; Poprach, Alexandr; Buchler, Tomas; Kopecký, Jindřich; Conteduca, Vincenza; Monteiro, Fernando Sabino Marques; Massari, Francesco; Gupta, Shilpa; Santoni, Matteo | 2025-01-01 | CLINICAL & EXPERIMENTAL METASTASIS | - | 1.01 Articolo in rivista | Clin Exp Med [ARON-2 Concomitant med EV].pdf |
| Correction to: The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor | Ricci, Costantino; Di Sciascio, Luisa; Ambrosi, Francesca; Grillini, Marco; Mollica, Veronica; Ma...ssari, Francesco; Fiorentino, Michelangelo; De Leo, Antonio; Idrees, Muhammad T.; Ulbright, Thomas M.; Acosta, Andres Martin | 2025-01-01 | VIRCHOWS ARCHIV | - | 1.01 Articolo in rivista | - |
| Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges | Danielli, Linda; Tassinari, Elisa; Marchetti, Andrea; Rosellini, Matteo; Mollica, Veronica; Cheng..., Liang; Massari, Francesco | 2025-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |
| Decreased Appetite in Cancer Patients Treated with immune checkpoint inhibitors (ICIs): The MOUSEION-012 Systematic Review and Meta-Analysis | Vitale, Elsa; Rizzo, Alessandro; Maistrello, Lorenza; Cauli, Omar; Mollica, Veronica; Marques Mon...teiro, Fernando Sabino; Soares, Andrey; Massari, Francesco; Santoni, Matteo | 2025-01-01 | CLINICAL NUTRITION ESPEN | - | 1.01 Articolo in rivista | - |
| Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era? | Marchetti, Andrea; Mollica, Veronica; Brocchi, Stefano; Cattabrigra, Arrigo; Tassinari, Elisa; Ro...sellini, Matteo; Massari, Francesco | 2025-01-01 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | - | 1.01 Articolo in rivista | 1005230.pdf |
| Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma | Santoni, Matteo; Mollica, Veronica; Rizzo, Alessandro; Massari, Francesco | 2025-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | 1001306.pdf |
| Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort | Fiala, Ondrej; Grillone, Francesco; Fujita, Kazutoshi; Grande, Enrique; Giannatempo, Patrizia; Ta...ha, Tarek; Myint, Zin W.; Büttner, Thomas; De Liaño, Alfonso Gómez; Kanesvaran, Ravindran; Facchini, Gaetano; Yano, Akihiro; Formisano, Luigi; Poprach, Alexandr; Conteduca, Vincenza; Pirshtuk, Alina; Studentova, Hana; Kopecky, Jindrich; Sammarco, Enrico; Mota, Augusto; Incorvaia, Lorena; Nasso, Cecilia; Maffezzoli, Michele; Ghose, Aruni; Soares, Andrey; Buti, Sebastiano; Marques Monteiro, Fernando Sabino; Massari, Francesco; Gupta, Shilpa; Bellmunt, Joaquim; Banna, Giuseppe Luigi; Santoni, Matteo | 2025-01-01 | EUROPEAN UROLOGY OPEN SCIENCE | - | 1.01 Articolo in rivista | EU Open Science [Aron-2 EV post chemio:Pembro].pdf; 1-s2.0-S2666168325014405-mmc1.docx |
| Feasibility and setting of single docking HUGO RAS robot-assisted nephroureterectomy: first European experience | Mottaran, Angelo; Piazza, Pietro; Dababneh, Hussam; Scarlatti, Riccardo; Catanzaro, Calogero; Pie...ri, Jacopo; Biolcati, Stefano; Droghetti, Matteo; Massari, Francesco; Chessa, Francesco; Bianchi, Lorenzo; Schiavina, Riccardo; Brunocilla, Eugenio | 2025-01-01 | MINERVA UROLOGY AND NEPHROLOGY | - | 1.01 Articolo in rivista | - |
| First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study | Roviello, Giandomenico; Molina-Cerrillo, Javier; Massari, Francesco; Cerbone, Linda; Fiala, Ondre...j; Fornarini, Giuseppe; Monteiro, Fernando Sabino Marques; Cattrini, Carlo; Landmesser, Johannes; Messina, Carlo; Zgura, Anca; Rebuzzi, Sara Elena; Soares, Andrey; Carrozza, Francesco; Ansari, Jawaher; Grillone, Francesco; Küronya, Zsófia; Incorvaia, Lorena; Bhuva, Dipen; Ortega, Cinzia; Nasso, Cecilia; Kanesvaran, Ravindran; Zampiva, Ilaria; Porta, Camillo; Buti, Sebastiano; Santoni, Matteo | 2025-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | Cancer Immunol Immunoth 2025 [ARON-1 Good Risk].pdf; 262_2024_3897_MOESM2_ESM.docx; 262_2024_3897_MOESM1_ESM.docx |